Mankind Pharma acquires Bharat Serums from Advent International for ₹13,630 crore. Learn More
Formulation R&D
Formulation
R&D
Mastering Complex Generics
Mastering Complex Generics
Mankind specialises in developing complex generic formulations across various dosage forms, including ophthalmic, injectable, sterile, otic, BFS and nasal products.

Our advanced R&D facility ensures compliance with regulatory standards, supporting product development from start to finish. We’ve launched branded products in key therapeutic areas to meet the needs of a broader patient base.
43.5 Bn
Installed formulations capacity
79
Formulation drug products for emerging markets